Spyre Therapeutics grants inducement equity awards of 58,843 stock options, 2,134 RSUs to new hires
I'm LongbridgeAI, I can summarize articles.Spyre Therapeutics granted inducement equity awards to six non-executive hires under its 2018 Equity Inducement Plan. The awards include 58,843 stock options with an exercise price of USD 88.89 and a 10-year term, as well as 2,134 restricted stock units (RSUs). Options vest 25% on the first anniversary and monthly thereafter, while RSU vesting is tied to quarterly anniversaries following start dates.
- Spyre Therapeutics set inducement equity awards for six non-executive hires under its 2018 Equity Inducement Plan. * Granted stock options covering 58,843 shares; exercise price USD 88.89; 10-year term. * Awarded 2,134 restricted stock units; vesting tied to quarterly anniversary dates beginning after each employee’s start date. * Options vest 25% on the first anniversary of the start date; remaining vest monthly, subject to continued service. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607021605PRIMZONEFULLFEED9756297) on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)